Integrated Diagnostics Holdings Statistics
Integrated Diagnostics Holdings (8I8) Stock Statistics & Valuation Metrics
Total Valuation
Integrated Diagnostics Holdings has a market cap or net worth of EUR 251.46M. The enterprise value is EUR 199.41M.
- Market Cap
- EUR 251.46M
- Enterprise Value
- EUR 199.41M
Share Statistics
Integrated Diagnostics Holdings has 581,326,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 581,326,300
- Owned by Insiders
- 59.35%
- Owned by Institutions
- 3.16%
Financial Efficiency
Integrated Diagnostics Holdings’s return on equity (ROE) is 0.37 and return on invested capital (ROIC) is 20.67%.
- Return on Equity (ROE)
- 0.37
- Return on Assets (ROA)
- 0.15
- Return on Invested Capital (ROIC)
- 20.67%
- Return on Capital Employed (ROCE)
- 0.36
- Revenue Per Employee
- 1.10M
- Profits Per Employee
- 176.85K
- Employee Count
- 7,137
- Asset Turnover
- 0.91
- Inventory Turnover
- 10.61
Valuation Ratios
The current PE Ratio of Integrated Diagnostics Holdings is 9.71. Integrated Diagnostics Holdings’s PEG ratio is 0.26.
- PE Ratio
- 9.71
- PS Ratio
- 1.59
- PB Ratio
- 3.72
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- 0.26
Income Statement
In the last 12 months, Integrated Diagnostics Holdings had revenue of 7.86B and earned 1.26B in profits. Earnings per share was 2.17.
- Revenue
- 7.86B
- Gross Profit
- 3.35B
- Operating Income
- 2.12B
- Pretax Income
- 2.12B
- Net Income
- 1.26B
- EBITDA
- 2.89B
- Earnings Per Share (EPS)
- 2.17
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Integrated Diagnostics Holdings pays an annual dividend of ―, resulting in a dividend yield of 5.07%
- Dividend Per Share
- ―
- Dividend Yield
- 5.07%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 10.34%
Stock Price Statistics
- Beta
- 0.03
- 52-Week Price Change
- -13.00%
- 50-Day Moving Average
- 0.41
- 200-Day Moving Average
- 0.44
- Relative Strength Index (RSI)
- 47.71
- Average Volume (3m)
- 11.60K
Important Dates
Integrated Diagnostics Holdings upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Integrated Diagnostics Holdings as a current ratio of 1.46, with Debt / Equity ratio of 47.68%
- Current Ratio
- 1.46
- Quick Ratio
- 1.31
- Debt to Market Cap
- 0.02
- Net Debt to EBITDA
- -0.02
- Interest Coverage Ratio
- 10.19
Taxes
In the past 12 months, Integrated Diagnostics Holdings has paid 816.89M in taxes.
- Income Tax
- 816.89M
- Effective Tax Rate
- 0.39
Enterprise Valuation
Integrated Diagnostics Holdings EV to EBITDA ratio is 5.09, with an EV/FCF ratio of 0.00.
- EV to Sales
- 1.60
- EV to EBITDA
- 5.09
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Integrated Diagnostics Holdings has EUR 1.96B in cash and marketable securities with EUR 1.68B in debt, giving a net cash position of EUR 278.32M billion.
- Cash & Marketable Securities
- EUR 1.96B
- Total Debt
- EUR 1.68B
- Net Cash
- EUR 278.32M
- Net Cash Per Share
- EUR 0.48
- Tangible Book Value Per Share
- EUR 4.91
Margins
Gross margin is 43.29%, with operating margin of 28.11%, and net profit margin of 16.49%.
- Gross Margin
- 43.29%
- Operating Margin
- 28.11%
- Pretax Margin
- 31.28%
- Net Profit Margin
- 16.49%
- EBITDA Margin
- 31.42%
- EBIT Margin
- 27.63%
Scores
- Smart Score
- 6
- AI Score
- ―
